STING1 and relapsing-remitting multiple sclerosis: Together, these data suggest that the STING/IFN-β pathway is significantly altered in the peripheral blood cells of patients with RRMS, indicating a vital immunomodulatory role of this pathway, not only in mice but also in humans.